Evidence map›Paper›PMID 40401027›Full record

ArticleFrontiers in neurology2025

Twitch force in human Amyotrophic Lateral Sclerosis.

Laura Libonati, Chiara Cambieri, Marco Ceccanti, Federica Moret, Matteo Di Giulio, Eleonora Palma, Maurizio Inghilleri

Abstract read
In one paragraph

Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laura LibonatiDepartment of Human Neurosciences, Rare Neuromuscular Diseases Center, Sapienza University of Rome, Viale Dell'Università, Rome, Italy.
Chiara CambieriDepartment of Human Neurosciences, Rare Neuromuscular Diseases Center, Sapienza University of Rome, Viale Dell'Università, Rome, Italy.
Marco CeccantiDepartment of Human Neurosciences, Rare Neuromuscular Diseases Center, Sapienza University of Rome, Viale Dell'Università, Rome, Italy.
Federica MoretDepartment of Human Neurosciences, Rare Neuromuscular Diseases Center, Sapienza University of Rome, Viale Dell'Università, Rome, Italy.
Matteo Di GiulioDepartment of Human Neurosciences, Rare Neuromuscular Diseases Center, Sapienza University of Rome, Viale Dell'Università, Rome, Italy.
Eleonora PalmaDepartment of Physiology and Pharmacology, Istituto Pasteur-Fondazione Cenci Bolognetti, University of Rome Sapienza, Rome, Italy.
Maurizio InghilleriDepartment of Human Neurosciences, Rare Neuromuscular Diseases Center, Sapienza University of Rome, Viale Dell'Università, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study investigated differences in muscle twitch force between slow and fast progressors of amyotrophic lateral sclerosis (ALS) to better understand disease heterogeneity and identify potential biomarkers of disease progression. Methods: Forty-four ALS patients were classified as slow or fast progressors based on disease progression rates. Electrophysiological assessments, including compound muscle action potential (CMAP) and muscle force measurements, were conducted. Creatine kinase (CK) levels were also evaluated. Results: Slow progressors demonstrated significantly higher muscle peak force and area under the curve (AUC) compared to fast progressors, reflecting greater muscle strength and endurance. CK levels were also elevated in slow progressors. Discussion: Despite similar CMA Conclusion: Muscle function profiles and CK levels are promising indicators of ALS progression. These findings could enhance early detection of disease progression and lead to targeted interventions to preserve muscle function. Further research is needed to validate these results and explore the underlying functional mechanisms of disease heterogeneity.

Indexed as

amyotrophic lateral sclerosisdisease phenotypedisease progressionelectromechanical couplingmuscle function

Identifiers

PMID40401027
PMCPMC12093408

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.